Unicycive Therapeutics Inc (UNCY) — Cash Flow Quality Index

Latest as of March 2025: -15.62x

Unicycive Therapeutics Inc (UNCY) has a Cash Flow Quality Index of -15.62x as of March 2025. Operating cash flow of $-8.90 Million is below net income of $570.00K, suggesting accrual-heavy earnings not yet converted to cash. Also explore UNCY total asset value for the complete picture of this company's asset base.

Cash Flow Quality Index

-15.62x

Operating CF / Net Income

Operating Cash Flow

$-8.90 Million

USD

Net Income

$570.00K

USD

Data as of

Mar 2025

Most recent filing

Annual Cash Flow Quality Index for Unicycive Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Unicycive Therapeutics Inc. For live market cap and the full company financial profile, see UNCY market cap overview.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.